Displaying drugs 14651 - 14675 of 15307 in total
Meptazinol
Experimental
Sambucus nigra flowering top
Experimental
Bacillus subtilis
Experimental
Lactobacillus helveticus
Experimental
Magnolia kobus bark
Experimental
Anemarrhena asphodeloides root
Experimental
Polygala tenuifolia root
Experimental
Minretumomab
Experimental
AMP-224
Investigational
Anise oil
Experimental
Alpinia officinarum leaf
Experimental
BacTRL-spike
BacTRL-Spike is composed of a bacterial medium with colony-forming-units of live Bifidobacterium longum engineered to deliver synthetic DNA encoding spike protein from SARS-CoV-2 contained by plasmids. The vaccine was developed by Symvivo Corporation. As of June, 2020, the company is pursuing a Phase 1, Randomized, Observer-Blind, Placebo-Controlled Trial (NCT04334980) to...
Investigational
Matched Description: … pursuing a Phase 1, Randomized, Observer-Blind, Placebo-Controlled Trial (NCT04334980) to test the safety and …
Cedar leaf oil
Experimental
Cajuput oil
Experimental
Nutmeg oil
Experimental
Receptor binding domain (RBD) SARS-CoV-2 (COVID-19) hepatitis B surface antigen (HBsAg) virus-like particle (VLP) vaccine
Receptor binding domain SARS-CoV-2 Hepatitis B surface antigen virus-like particle vaccine (RBD SARS-CoV-2 HBsAg VLP vaccine), is a virus-like particle vaccine candidate where the RBD antigen is conjugated to the hepatitis B surface antigen . Virus-like particles (VLPs) are protein-based vaccines that stimulate high immune responses because of the VLPs’...
Investigational
Lactobacillus salivarius
Experimental
Medicago sativa top
Experimental
Nux vomica extract
Experimental
Mentha arvensis leaf oil
Experimental
Pelargonium sidoides root
Experimental
Pinus densiflora whole
Experimental
Thyme oil
Experimental
Displaying drugs 14651 - 14675 of 15307 in total